Journey Medical Corp (DERM) — Cash Flow-to-Debt Ratio
Journey Medical Corp (DERM) has a Cash Flow-to-Debt Ratio of -0.10x as of December 2025, meaning its operating cash flow of $-6.36 Million could theoretically repay 0% of its total liabilities ($62.74 Million) in one year. Check Journey Medical Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Journey Medical Corp Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Journey Medical Corp across 12 annual periods. Also explore Journey Medical Corp (DERM) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Journey Medical Corp (2014–2025)
Year-by-year debt coverage analysis for Journey Medical Corp. For market capitalisation and broader financial context, see Journey Medical Corp stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | $-12.44 Million | $62.74 Million | ▼ -30.7% |
| 2024 | -0.15x | $-9.13 Million | $60.17 Million | ▼ -263.5% |
| 2023 | 0.09x | $5.24 Million | $56.50 Million | ▲ +160.4% |
| 2022 | -0.15x | $-13.53 Million | $88.18 Million | ▼ -288.8% |
| 2021 | -0.04x | $-2.18 Million | $55.24 Million | ▼ -132.0% |
| 2020 | 0.12x | $5.13 Million | $41.61 Million | ▼ -57.5% |
| 2019 | 0.29x | $9.02 Million | $31.11 Million | ▲ +148.1% |
| 2018 | -0.60x | $-213.10 Million | $353.36 Million | ▼ -138.5% |
| 2017 | -0.25x | $-103.96 Million | $411.14 Million | ▲ +77.7% |
| 2016 | -1.14x | $-74.11 Million | $65.23 Million | ▲ +14.5% |
| 2015 | -1.33x | $-48.44 Million | $36.46 Million | ▼ -4.3% |
| 2014 | -1.27x | $-31.40 Million | $24.64 Million | — |